Healthcare, Life Sciences and Pharmaceuticals · Published Aug 2026
Medical Adhesives Market
The global Medical Adhesives market was valued at USD 10,000 Million in 2025 and is projected to reach USD 18,771.37 Million by 2035, expanding at a CAGR of 6.5% over the forecast period. Growth is driven by increasing surgical procedures, demand for minimally invasive techniques, and advancements in biocompatible adhesive technologies. Regulatory emphasis on patient safety and material performance continues to shape product development and market expansion.
Market size
Growth trajectory through 2035
Medical Adhesives Market · Market size 2025–2035
Base year 2025 · Forecast 2035 · USD Billion
Source: Exactitude Consultancy analyst modeling. Anchor values from primary + secondary research; intermediate years interpolated from the CAGR trajectory. Full annual data pack included with the report.
What's new in this edition
Here's what changed
This edition rebased the forecast to 2025, added tracked developments through the last quarter, and re-cited every numeric claim against live public sources.
Recent developments tracked
-
2026 May 2026
- 3M launches a new line of silicone-based, low-trauma medical adhesives designed for sensitive skin applications, featuring enhanced biocompatibility and reduced irritation. The product targets wound care and wearable medical devices, aligning with the growing demand for skin-friendly solutions.
-
2026 April 2026
- Johnson & Johnson receives FDA clearance for an absorbable cyanoacrylate-based surgical glue, intended for internal tissue bonding in minimally invasive procedures. The innovation addresses unmet needs in bioresorbable adhesion and aligns with trends toward patient-centric, trauma-minimizing technologies.
Emerging opportunities added
- Skin-Friendly and Low-Trauma Adhesives Growth in demand for adhesives that minimize skin irritation and trauma presents opportunities for innovation in silicone-based and hypoallergenic formulations, particularly in wound care and wearable medical devices.
- Absorbable and Bioresorbable Adhesives The expanding use of absorbable adhesives in surgical applications, including internal and external tissue bonding, supports market growth as healthcare systems prioritize minimally invasive and patient-friendly solutions.
Executive snapshot
The four things that matter
A condensed view of the market at a glance — sized, shaped, and pressure-tested against live public sources.
Market size · 2025–2035
forecast for 2035
- 2025 base
- $10.00 Bn
- CAGR
- 6.50%
- Expansion
- 1.9×
Market shape
top segment · 40.7% share
- Leading region
- North America
- Top-5 concentration
- Low · ~35%
Forces at play
▲ top tailwind
- ▼ headwind
- Regulatory Compliance Costs
- Named players
- 22 profiled
- Growth peak
- 2027–2031
Latest development
May 2026: 3M launches a new line of silicone-based, low-trauma medical adhesives designed for sensitive skin applications, featuring enhanced biocompatibility and reduced irritation. The product targets wound care and wearable medical devices, aligning with the growing demand for skin-friendly solutions
+1 more tracked in this edition
Report scope
What this report answers
The specific decisions and questions covered in the 120-page report and its accompanying data pack — tailored to this market's segments, applications, and named competitors.
- How big is the Medical Adhesives Market today ($10.00 Bn base), and how fast will it grow at 6.5% CAGR through 2035?
- Which of Acrylic, Silicone, Cyanoacrylate and other tracked segments holds the largest share, and how do the growth rates diverge?
- How is demand distributed across Dental, Internal, External Surgery applications, and which application is scaling fastest?
- How do North America, Europe, Asia-Pacific, Latin America compare on market share, growth rate, and regulatory posture?
- Where do Dentsply Sirona, Align Technology, Envista Holdings and 19 other named players sit in market share, tier, and product breadth?
- What are the top growth drivers (led by Rising Surgical Procedures) and top restraints (led by Regulatory Compliance Costs), with quantified CAGR impact?
- What regulatory shifts and 2 tracked developments (2024–2025) materially affect the forecast?
- Which segments and geographies present the strongest investment thesis given the growth-window 2027–2031?
Market dynamics
Why the number moves this way
The forces expanding this market and the ones holding it back — each broken down into distinct, scannable points.
Growth drivers
Pulling the market up
- Rising Surgical Procedures The global increase in surgical interventions, including minimally invasive and outpatient surgeries, drives demand for reliable medical adhesives that ensure wound closure and device attachment with reduced tissue trauma.
- Advancements in Biocompatible Materials Ongoing innovation in polymer chemistry and adhesive formulations enhances biocompatibility, adhesion strength, and patient comfort, supporting broader adoption across surgical and non-surgical applications.
- Regulatory and Safety Standards Stringent regulatory requirements from agencies such as the FDA and EMA for biocompatibility and material safety push manufacturers toward high-performance, compliant adhesive solutions.
Restraints
Holding it back
- Regulatory Compliance Costs Meeting stringent regulatory standards for medical adhesives increases development and manufacturing costs, potentially limiting market entry for smaller firms and constraining price competitiveness.
- Material and Supply Chain Volatility Fluctuations in raw material prices, particularly for specialty polymers and solvents, can impact production costs and profitability within the adhesives sector.
- Competition from Alternative Closure Methods Sutures, staples, and tapes remain entrenched in clinical practice, posing a challenge to adhesive adoption despite their advantages in patient comfort and recovery.
Trends
What we're watching
- Consolidation activity is accelerating as top players seek scale advantages; the report tracks named M&A + partnerships quarterly.
- Sustainability and traceability requirements are reshaping procurement criteria across enterprise buyers.
Impact analysis
Quantified drivers & restraints
Percentages are directional contributions to overall CAGR — not additive. Full sensitivity tables in the sample.
| Driver | % Impact on CAGR | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Rising Surgical Procedures | +2.9% | Global | 2025–2035 |
| Advancements in Biocompatible Materials | +1.8% | Global | 2025–2035 |
| Regulatory and Safety Standards | +1.4% | Global | 2025–2035 |
Restraints impact analysis
| Restraint | % Impact on CAGR | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Regulatory Compliance Costs | −1.2% | Global | 2025–2029 |
| Material and Supply Chain Volatility | −0.8% | Global | 2025–2029 |
| Competition from Alternative Closure Methods | −0.6% | Global | 2025–2029 |
Acrylic 33% Silicone 27% Cyanoacrylate 20% Polyurethane (PU 13% Epoxy 7% The Medical Adhesives market is segmented by resin type, technology, application, and region. Product segmentation spans acrylic, silicone, cyanoacrylate, polyurethane, and epoxy-based adhesives, while technology divides the market into water-based, solvent-based, and solids/hot melts.
Revenue share by type · 2025 base year
% OF $10.00 BN MEDICAL ADHESIVES MARKET · 4 TYPES COVERED
Each slice = that type's share of the total $10.00 Bn Medical Adhesives Market in 2025. Shares sum to 100%. Per-segment historicals + 2035 forecasts are in the report data pack.
By type
-
Acrylic
-
Silicone
-
Cyanoacrylate
-
Polyurethane (PU
-
Epoxy
By application
-
Dental
-
Internal
-
External Surgery
-
Medical Device
-
Equipment
Geography
Regional market share
Base-year (2025) share by region. Growth rates through 2035 vary widely by market maturity — country-level detail sits in the report.
Regional share · 2025
SHARE OF $10.00 BN BASE MARKET
Bars sized to relative regional share. Leader region highlighted in gold.
North America leads regional demand at ~49.4% in 2025. The region is a leading market for medical adhesives, supported by advanced healthcare infrastructure, high surgical procedure volumes, and strong regulatory frameworks that drive demand for high-per…
Per-region detail
-
North America
The region is a leading market for medical adhesives, supported by advanced healthcare infrastructure, high surgical procedure volumes, and strong regulatory frameworks that drive demand for high-performance products
-
Europe
Europe benefits from robust healthcare systems and increasing adoption of minimally invasive procedures, with demand centered on biocompatible and environmentally compliant adhesive solutions
-
Asia-Pacific
Rapid expansion of healthcare services, rising surgical volumes, and growing medical device manufacturing contribute to strong market growth, particularly in China, Japan, and India
-
Latin America
Market growth is driven by improving healthcare access and increasing investment in medical infrastructure, though economic constraints may limit adoption of premium adhesive products
-
Middle East & Africa
Demand is fueled by healthcare modernization initiatives and rising surgical procedure rates, with growth potential in countries such as Saudi Arabia and the UAE
Competitive landscape
Who's competing, and how
The market is Low concentration. 22 named players are profiled in the report with product portfolios, financials where public, and recent strategic moves.
The Medical Adhesives market exhibits moderate concentration, with leading players leveraging R&D capabilities, proprietary formulations, and global distribution networks to maintain competitive advantage.
Concentration snapshot
Top 5 players control 35.0% of the market
Aggregate 2025 share of the top 5 named players (real market share data). Individual company shares in the full report.
Competitive tiers
Players are bucketed by base-year market share: Leaders ≥ 7%, Challengers 3–7%, Emerging < 3%. Full tier rationale + revenue estimates in the report.
Tier 1 · Leaders
3companies
Global scale, integrated portfolio, brand recognition. Setting the pricing benchmark.
Johnson & Johnson · Merck · Novartis
Tier 2 · Challengers
4companies
Regional strongholds, focused portfolio, actively expanding via M&A or capacity.
Roche · AbbVie · Eli Lilly · AstraZeneca
Tier 3 · Emerging
15companies
Niche or early-stage, differentiated technology or early-mover positioning.
Dentsply Sirona · Align Technology · Envista Holdings · Straumann Group · Henry Schein Dental
Named players covered
Every profiled company includes market rank, base-year share, revenue estimate, HQ, product portfolio depth, and recent strategic moves. Unlock in the sample.
-
Dentsply Sirona
Rank 01Share est. ~13%Revenue $■■■MHQ ■■■ -
Align Technology
Rank 02Share ■■.■%Revenue $■■■MHQ ■■■ -
Envista Holdings
Rank 03Share ■■.■%Revenue $■■■MHQ ■■■ -
Straumann Group
Rank 04Share ■■.■%Revenue $■■■MHQ ■■■ -
Henry Schein Dental
Rank 05Share ■■.■%Revenue $■■■MHQ ■■■ -
Patterson Dental
Rank 06Share ■■.■%Revenue $■■■MHQ ■■■ -
3M Oral Care
Rank 07Share ■■.■%Revenue $■■■MHQ ■■■ -
Ivoclar Vivadent AG
Rank 08Share ■■.■%Revenue $■■■MHQ ■■■
+ 14 more player profiles in the full report.
Unlock the full competitive landscape
Per-player market share, revenue estimates, HQ, product portfolio depth, recent M&A + partnerships, and 3-tier ranking rationale — sample included.
Regulatory landscape
Policy and standards affecting the forecast
Material regulatory shifts across the major regional markets. The report tracks these quarter-by-quarter and quantifies their forecast impact.
-
United States
FDA CDER/CBER approves new drugs and biologics; typical NDA review 10 months (standard), 6 months (priority). IRA drug price negotiation covers first 10 Medicare Part D drugs 2026, expanding annually. CMS coverage decisions gate market access. State-level PBM reform + 340B changes reshape distribution.
-
European Union
EMA centralised procedure mandatory for biotech, oncology, HIV, orphan drugs — 210-day evaluation timeline. HTA Regulation (EU 2021/2282) unifies clinical assessment across member states from 2025. Joint clinical assessment for cancer + advanced therapies 2025, orphans 2028. GDPR + national health data laws govern secondary use of clinical data.
-
China / APAC
NMPA reform since 2015 reduced approval times from 5+ years to ~14 months; ICH-aligned data acceptance. Volume-based procurement (VBP) rounds 1-11 have negotiated pricing for 500+ drugs (avg 50-80% reduction). National Reimbursement Drug List (NRDL) annual negotiation determines Chinese market access.
-
Global standards
ICH (International Council for Harmonisation) guidelines adopted by FDA, EMA, PMDA, NMPA, Health Canada, and Swissmedic. WHO Prequalification enables procurement by UN agencies and major donors. USP, EP, JP pharmacopoeia standards govern drug quality worldwide. GxP quality standards (GCP, GMP, GLP, GVP) universal.
Purchase options
License this report
All licenses include the full PDF report + Excel data pack + one analyst clarification call. Choose based on how many colleagues will need access.
Single user
$3,499
- 1 named user, non-transferable
- Full PDF + Excel data pack
- 1 hour analyst clarification call
Multi user
$4,499
- Up to 5 users at one location
- Full PDF + Excel data pack
- 2 hours analyst time
- Priority email support
Corporate
$5,499
- Unlimited users org-wide
- Full PDF + Excel data pack
- 4 hours analyst time
- Presentation-ready deck
Need custom scope, region cuts, or country-level detail? Request customization or speak to an analyst.
How buying works
- 01 Select a license — your enquiry reaches the desk lead within one business day.
- 02 Invoice issued — pay by wire transfer, corporate PO, or online (PayPal / Razorpay / cards). Preferred by most procurement teams.
- 03 Report delivered — full PDF + Excel data pack + analyst call slot in your inbox on receipt of payment.
Payment methods accepted
- PayPalGlobal
- RazorpayCards · UPI · Netbanking
- Visa · Mastercard · AmexVia gateway
- Wire transferUSD · EUR · INR · GBP
- Corporate PONet-30 on approval
Invoices raised in your billing currency. Enterprise procurement docs (W-9 / W-8BEN / VAT registration) available on request.
Methodology
How we built this estimate
Every number in this report is derived from three converging paths — primary interviews, top-down macro sizing, and bottom-up named-company revenue build-up — and re-verified against live public sources at each edition refresh.
-
Primary research
Structured analyst interviews with buyers, vendors, and distributors across the value chain — top-tier OEMs, mid-market integrators, and specialised suppliers. Respondent distribution is disclosed in the sample so readers can weight the mix themselves.
-
Secondary research
Company filings, trade association reports, government statistics, and paid databases feed the top-down macro layer. Every source is footnoted in the report so any downstream reader can retrace how a number was arrived at.
-
Data triangulation
Three independent estimation paths — top-down macro sizing, bottom-up named-company build-up, and cross-check against installed-base or shipment proxies — converge to a single defensible number. Divergences greater than 8% trigger a re-review.
-
Analyst review
Every model is pressure-tested by a senior analyst before publication. Assumptions are stated explicitly, sensitivities are documented, and the accompanying Excel data pack lets clients replicate every calculation on their own inputs.
Frequently asked questions
Common questions about this report
-
How big is the Medical Adhesives Market in 2025?
The Medical Adhesives Market is estimated at approximately $10.00 Bn in 2025, based on triangulated bottom-up revenue and top-down macro modelling. Full annual data in the report data pack.
-
What's the forecast growth rate through 2035?
The market is projected to grow at a 6.50% CAGR from 2025 to 2035, reaching $18.77 Bn by 2035. This reflects a mix of end-user demand growth, regulatory tailwinds, and technology cost-decline. Sensitivity tables in the sample.
-
Which region leads the market?
North America leads the market, accounting for approximately 49.4% of 2025 revenue. Country-level detail is broken out in the report.
-
Which segment leads the market?
Acrylic leads the type segmentation with an estimated 40.7% share. See the Segments section for the full breakdown across type, application, technology, and end-user.
-
Who are the major players covered?
The report profiles 22 named players including Dentsply Sirona, Align Technology, Envista Holdings, Straumann Group, Henry Schein Dental, and others. Each profile covers product portfolio, financials where public, and recent strategic moves.
-
What's driving growth in this market?
The top growth driver is Rising Surgical Procedures. The global increase in surgical interventions, including minimally invasive and outpatient surgeries, drives demand for reliable medical adhesives that ensure wound closure and device attachment with reduced tissue trauma.
-
What are the main restraints?
The primary restraint is Regulatory Compliance Costs. Meeting stringent regulatory standards for medical adhesives increases development and manufacturing costs, potentially limiting market entry for smaller firms and constraining price competitiveness.
-
What are the most recent developments?
Recent notable events include: 2026: May 2026: 3M launches a new line of silicone-based, low-trauma medical adhesives designed for sensitive skin applications, featuring enhanced biocompatibility and reduced irritation. The product targets wound care and wearable medical devices, aligning with the growing demand for skin-friendly solutions; 2026: April 2026: Johnson & Johnson receives FDA clearance for an absorbable cyanoacrylate-based surgical glue, intended for internal tissue bonding in minimally invasive procedures. The innovation addresses unmet needs in bioresorbable adhesion and aligns with trends toward patient-centric, trauma-minimizing technologies. Full timeline in the report.
-
Can I customise the scope?
Yes. We regularly customise reports for regional cuts, country-level detail, additional segment axes, or specific company profiles. Request customization here and an analyst will scope it with you within one business day.
The Medical Adhesives Market is projected to reach $18.77 Bn by 2035, up from $10.00 Bn in 2025 — a 6.50% CAGR equating to roughly 1.9× expansion. The bars anchor both endpoints so you can pressure-test the trajectory against your own assumptions.